About

Currently the need for skin examination (including health and beauty) is poorly served. Each dermatologist in Europe corresponds to 10K people and as malignancy rates increase practically no commercial system can counter-balance this trend. Current systems have low adoption due to cost, they are slow, bulky, and not automated. More importantly, they don’t allow for other health care professionals to assist with the process, such as GPs, Pharmacists, Aestheticians and as a result the aforementioned ratio of doctors per person cannot be improved.

Solution & Product

Althexis is introducing, an Innovative Platform technology which focuses on two levels, a Technological and a Social one. At the Technological Level, we deliver a Multispectral imaging system coupled with AI, offering automation, speed & diagnostic accuracy. At the Social level, we offer Althexis Social Cloud, an ecosystem of widgetized apps.. customizable for skin-health and skin-beauty products. In such a way, we enable Pharmacists, Aestheticians and General Practitioners to join forces with the doctors in the skin examination effort, by accessing the same disruptive technology. From a business perspective we expand the digital dermoscopy market as we transfer skin examination technology from Doctors to Pharmacists, Aestheticians and non skin-experts in general. We also invest on a bigger vision as we collect very rich, annotated skin data able to power more products in the future. The Value Proposition for the Doctors is an affordable, analytical tool to speedup their daily practice, assist the examination process and upgrade the overall examination procedure. For pharmacists and aestheticians it's a marketing tool to promote their services and products by offering to their clients various free skin examinations and beauty applications connecting skin screening with personalized sales.

Innovation & Scalability

Our startup incorporates both technology and business innovation by revolutionizing the current device-oriented business model to a versatile skin platform ecosystem. With this strategy we manage to largely extend our potential customers, create skin awareness and collect (for the first time) multispectral data characterized by diagnosis and/or treatment. Briefly: •Multispectral technology coupled with AI. •In-house Multispectral camera that minimizes the production cost making such technology truly accessible. •Versatile platform technology which offers a variety of applications to different stakeholders beyond doctors. •High quality data collection cloud infrastructure with precision labeling to support the development of future innovative products and the vision of future innovative products. We implement a subscription-based plan with leased hardware (i.e Althexis Multispectral Camera). Depending on the target market we exploit the following market channels: -Door-to-door for key sales (e.g big private skin/aesthetics clinics. -Through distributors of pharmaceutical/medical products. -Pharmacists associations&suppliers. Our solution is scalable since we: -Implement a common platform technology for all products & markets. -Offer widgetized products that can quickly mix and match with our customers' needs ensuring quick market fit. -In-house and low-cost multispectral dermoscope that can be produce/outsourced in any volume.

Traction & achievements

Technological Maturity: We developed tested and verified at the market a complete product lineup: In-house developed multispectral dermoscope with 14-spectral bands (competition offers conventional 3-band sensors) Cloud based platform Stand alone desktop and Android app Widgetized software for Dermatologists, Aestheticians, Pharmacists Market Traction: We have initial traction in all the aforementioned markets (with cold sales or sales with trial period) and we currently assess the value proposition for each of them. The pricing plan is a subscription-based service with a leased multispectral dermoscope. We are also scientifically supported by a major University hospital in Greece.

Team & Why Us

. Thanasis Papathanasiou MSc (Founder & CTO, Multispectral expert). Senior Software Engineer experienced in Multispectral Imaging technology. . Antonis Nikitakis Phd (Founder & CEO, AI expert). He has more than 20 publications in international journals and conferences in embedded/hardware design, computer vision and AI. . Dimitris Markelos (Commercial Manager, Medical Physics MSc). . Nikos Koutroumpinis (Head of Dev & AI, Software expert).

Funding Needs

Althexis aims to utilize €500K to 1M of equity funding to implement our business plan in a 14-month time horizon. For more info regarding our business plan do not hesitate to contact us.